Angus Dalgleish

FMedSci FRACP FRCP
Angus Dalgleish, March 2016
BornMay 1950 (age 73)[1]
Harrow, London, England
Alma materUniversity College London
EmployerSt George's, University of London
Known forHIV/AIDS research[2]
Political partyUK Independence Party (UKIP)
Websitewww.sgul.ac.uk/profiles/gus-dalgleish

Angus George Dalgleish (born May 1950) FRCP FRCPath FMedSci[2] is a professor of oncology at St George's, University of London, best known for his contributions to HIV/AIDS research.[3][4][5][6] Dalgleish stood in 2015 for Parliament as a UKIP candidate.

Education

Angus George Dalgleish was born in May 1950 in Harrow, London.[1][7][8] Initially educated at the Harrow County School for Boys,[7] Dalgleish received a Bachelor of Medicine, Bachelor of Surgery degree from University College London with an intercalated bachelor's degree in Anatomy.[7]

Career as medical researcher

After various positions in the United Kingdom, Dalgleish joined the Royal Flying Doctor Service in Mount Isa, Queensland, then progressed through positions at various hospitals in Brisbane, Australia, before moving to the Ludwig Institute for Cancer Research in Sydney.[7][8]

After completion of his training, Dalgleish returned to work in the UK in 1984 at the Institute of Cancer Research.[7][8] He is a co-discoverer of the CD4 receptor as the major cellular receptor for HIV.[9] [10][11][12] In 1986, he was appointed to a consulting position at Northwick Park Hospital, in 1991 he was made Foundation Professor of Oncology at St George's, University of London,[7] and in 1994 he was appointed Visiting Professor at the Institute of Cancer Research in London.[13]

In 1997, he founded Onyvax Ltd.,[1] a privately-funded biotechnology company developing cancer vaccines, where he held the position as Research Director;[14] it was dissolved in 2013.[15] Dalgleish is a member of the medical board in Bionor Pharma. Dalgleish is on the scientific advisory board of Immodulon, and has stock options in Immunor AS, a disclosure he made in order to have his research work published.[16]

During the COVID-19 pandemic, Dalgleish was a proponent of the lab leak theory.[17]

2015 candidacy for Parliament

Dalgleish was a member of the UK Independence Party and stood as a candidate in Sutton & Cheam,[18][19] during the 2015 United Kingdom general election finishing fourth with 10.7% of the vote.[20] Dalgleish campaigned for Leave.EU[21] and appeared on the BBC Radio 4 Today programme presenting the case for Brexit.[22][18][23][24] He was an advocate of Leave Means Leave, a Eurosceptic group.[25]

Awards and honours

Dalgleish was elected a Fellow of the Academy of Medical Sciences in 2001[2] and is also a Fellow of the Royal College of Physicians the Royal College of Pathologists and a Fellow of the Royal Australasian College of Physicians.[23] His citation on election to FMedSci reads:

Professor Angus Dalgleish is Professor of Oncology at St Georges Hospital Medical School London. He has made seminal observations relating to the virology of HIV. In particular he identified CD4 as a major receptive for HIV in humans, produced the first report of a link between Slim Disease in Africa and HIV infection. He also identified the close correlation between the immune response and the presence of tropical spastic paraparesis in patients infected with the HTLV-1 virus.[2]

Controversies

In October 2023, following a joint investigation analysing emails leaked in 2022 by Russian hacking group working for the Russian FSB, an article was published by Computer Weekly[26] and Byline Times[27] containing several controversial claims about Angus Dalgleish.

  • That Dalgleish was a member of a secret group led by Richard Dearlove (former head of MI6), Gwythian Prins (a historian academic), and John Constable (of the Global Warming Policy Foundation) - who called themselves the "Covid Hunters".
  • That in March 2020 the group prepared an 'Urgent Briefing for the Prime Minister and his Advisers' which advised that COVID-19 originated in the Wuhan Institute of Virology (see COVID-19 lab leak theory).
  • That the group had briefed Boris Johnson that the man-made nature of the virus meant that the best candidate for vaccine development was the Norwegian Biovacc-19.[28] Also that Dalgleish had been given stock options in the company Immunor which held the patents for this vaccine due to his significant involvement in the research behind its development.
  • That when the scientific journal Nature Medicine published an article[29] contradicting their viewpoints on the origin of COVID-19, the group considered this to be COVID-19 misinformation by China.
  • That following these suspicions the group had advised Michael Gove to secretly start electronic surveillance on the journal using MI5 resources to uncover them as part of a “China Persons of Influence Network” of senior officials, politicians and academics allegedly under the influence of the communist state. (For examples, see Chinese information operations and information warfare and Chinese espionage in the United States.)
  • That the group had then contacted a range of other Western intelligence agencies to brief them on the supposed Chinese activity in a briefing titled 'The Three Interlocking Arms of The Intelligence Case against PRC' which claimed China was “attempting to control the terms of the origin of COVID-19 debate with active help from non-Chinese agents of influence, notably at the scientific journal Nature.
  • That the group had worked together previously to replace Theresa May with Boris Johnson and had previously attempted to replace the National Security Council.

Publications and contributions

According to Semantic Scholar Dr. Dalgleish has 495 publications, 21,234 citations, and 541 "highly influential citations".[30]

  • Smith PL; Piadel K; Dalgleish AG (25 November 2021). "Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy". Vaccines. Basel. 9 (12): 1392. doi:10.3390/vaccines9121392. PMC 8708201. article number 1392. in Special Issue Cancer Immunotherapy and Vaccines Research
  • Sørensen, B; Susrud, A; Dalgleish, AG (2 June 2020). "Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity". QRB Discovery. 1: e6. doi:10.1017/qrd.2020.8. PMC 7468800.

Bibliography

  • Barnard, Paolo; Quay, Steven; Dalgleish, Angus (2021). The Origin of the Virus: The hidden truths behind the microbe that killed millions of people. Clinical Press Ltd. ISBN 978-1-85-457107-6.

References

  1. 1 2 3 "Angus George DALGLEISH, born May 1950". London: Companies House, Government of the United Kingdom. Archived from the original on 5 July 2016.
  2. 1 2 3 4 Anon (2001). "Professor Angus Dalgleish FMedSci". acmedsci.ac.uk. London: Academy of Medical Sciences. Archived from the original on 5 July 2016.
  3. ↑ Dalgleish, Angus; Whelan, M (2005). "Novel immunotherapeutic approaches to prostate cancer". Current Opinion in Molecular Therapeutics. 7 (1): 30–34. PMID 15732527.
  4. ↑ Dalgleish, Angus (1995). "HIV and CD26". Nature Medicine. 1 (9): 881–2. doi:10.1038/nm0995-881. PMID 7585208. S2CID 2132301.
  5. ↑ Stephen Ward; David Casey; Marie-Christine Labarthe; Michael Whelan; Angus Dalgleish; Hardev Pandha; Stephen Todryk (September 2002). "Immunotherapeutic potential of whole tumour cells". Cancer Immunology, Immunotherapy. 51 (7): 351–357. doi:10.1007/s00262-002-0286-2. PMID 12192534. S2CID 8959770.
  6. ↑ "Professor Angus Dalgleish". sgul.ac.uk. London: University of London. Archived from the original on 6 April 2016.
  7. 1 2 3 4 5 6 "Angus Dalgleish Biography". St. George's University of London. Archived from the original on 16 June 2008. Retrieved 10 October 2008.
  8. 1 2 3 "Angus Dalgleish Biography". London Oncology Clinic. Archived from the original on 6 October 2008. Retrieved 10 October 2008.
  9. ↑ Dalgleish, Angus G.; Beverley, Peter C. L.; Clapham, Paul R.; Crawford, Dorothy H.; Greaves, Melvyn F.; Weiss, Robin A. (1984). "The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus". Nature. 312 (5996): 763–767. Bibcode:1984Natur.312..763D. doi:10.1038/312763a0. PMID 6096719. S2CID 4349809.
  10. ↑ Wilks, David; Dalgleish, Angus (1992). Molecular and Cell Biology of Sexually Transmitted Diseases. Springer. p. 283. ISBN 978-0-412-36510-2.
  11. ↑ "Biography". Hasumi International Research Foundation. Archived from the original on 21 November 2008. Retrieved 10 October 2008.
  12. ↑ Berridge, Virginia (1996). AIDS in the UK. Oxford University Press. p. 52. ISBN 978-0-19-820473-2.
  13. ↑ Angus Dalgleish's publications indexed by the Scopus bibliographic database. (subscription required)
  14. ↑ "Corporate Fact Sheet" (PDF). Onyvax Ltd. Archived from the original (PDF) on 7 December 2004. Retrieved 10 October 2008.
  15. ↑ "ONYVAX LIMITED". Companies House Service. Retrieved 23 November 2019.
  16. ↑ Sørensen, B.; Susrud, A.; Dalgleish, A.G. (2020). "Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity" (PDF). QRB Discovery. 1: e6. doi:10.1017/qrd.2020.8. PMC 7468800. PMID 34192262. S2CID 219811749.
  17. ↑ O'Neill, Sean (21 May 2021). "UK scientist feels vindicated as focus turns to Wuhan lab". The Times. Retrieved 19 January 2022.
  18. 1 2 Angus Dalgleish (2015). "Angus Dalgleish: 2015 Parliamentary Candidate for Sutton & Cheam + Representative for Cheam". UKIP Sutton Borough. Archived from the original on 5 March 2016.
  19. ↑ Murphy-Pyle, Mike (4 March 2014). "Cancer expert Professor Angus Dalgleish to stand for UKIP in Sutton and Cheam". Sutton Guardian. Retrieved 29 April 2015.
  20. ↑ "UK Polling Report". ukpollingreport.co.uk. Archived from the original on 18 November 2021. Retrieved 10 May 2015.
  21. ↑ Anon (2016). "Is this doctor (and UKIP candidate) right that EU migrants will destroy the NHS?". The Guardian. London. Archived from the original on 22 April 2016.
  22. ↑ Roy Greenslade (2016). "Scientist complains to BBC about being misled over Radio 4 interview". The Guardian. London. Archived from the original on 1 July 2016.
  23. 1 2 Angus Dalgleish (2016). "Consultant oncologist Angus Dalgleish". leave.eu. Archived from the original on 14 June 2016.
  24. ↑ Cressey, Daniel (2016). "Academics across Europe join 'Brexit' debate". Nature. 530 (7588): 15. Bibcode:2016Natur.530...15C. doi:10.1038/530015a. PMID 26842034.
  25. ↑ "Co-Chairmen – Political Advisory Board – Supporters". Leave Means Leave. Archived from the original on 24 October 2017. Retrieved 26 February 2018.
  26. ↑ "Top science journal faced secret attacks from Covid conspiracy theory group". Computer Weekly. 3 October 2023. Retrieved 3 October 2023.
  27. ↑ Campbell, Duncan; Goodwin, Bill; Taylor, Guy (2 October 2023). "The Brexit Conspiracy Files: Top Science Journal Faced Secret Attacks". Byline Times. Retrieved 15 October 2023.
  28. ↑ Sørensen, Birger; Susrud, Andres; Dalgleish, Angus George (2020). "Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity". QRB discovery. pp. e6. doi:10.1017/qrd.2020.8.
  29. ↑ Andersen, Kristian G.; Rambaut, Andrew; Lipkin, W. Ian; Holmes, Edward C.; Garry, Robert F. (April 2020). "The proximal origin of SARS-CoV-2". Nature Medicine. 26 (4): 450–452. doi:10.1038/s41591-020-0820-9. ISSN 1546-170X. PMC 7095063.
  30. ↑ "A. Dalgleish". www.semanticscholar.org. Semantic Scholar. Retrieved 6 January 2024.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.